Ivy Fertility Showcases Innovative Research at 2025 American Society for Reproductive Medicine Conference

Audio By Carbonatix

SAN DIEGO--(BUSINESS WIRE)--Nov 6, 2025--

Physicians and researchers from Ivy Fertility, a globally-recognized network of fertility centers, shared cutting-edge presentations and posters at the 2025 American Society for Reproductive Medicine (ASRM) Conference in San Antonio, Texas last week. Members of the clinical team also participated in talks, roundtables, and symposiums focused on improving care and outcomes for fertility patients.

“Ivy Fertility is committed to combining compassionate patient care with scientific innovation,” said Ivy Fertility CEO Lisa Van Dolah. “Presenting our research at ASRM allows us to share breakthroughs that can directly improve outcomes and enhance the fertility journey for patients everywhere.”

The following research presented by Ivy Fertility physicians and affiliated researchers highlight significant findings that contribute to the field of reproductive medicine.

Overcoming Financial Barriers to High Quality Genetic Services in the IVF Clinic
Speaker: Lauren Thomas Garrett MS, Certified Genetic Counselor (Pacific Northwest Fertility and Ivy Fertility)

This roundtable session addressed the financial barriers fertility centers face when striving to offer essential genetic testing services. It also explored cost-effective solutions to help clinics maintain the highest-quality genetic care.

Faster and Smarter: Leveraging Technology to Maximize Business Efficiency
Chair: Lowell Ku MD (Dallas IVF)
Speakers: John Preston Parry MD, Hary Hokianto MD, David B Sable MD

This interactive session explored strategies for growing REI practices with limited resources by leveraging technology to improve efficiency, patient care, and team-based operations. Through audience polling and rapid-fire pearls from panelists, participants identified top technology concerns, shared practical solutions, and discussed emerging opportunities in cybersecurity, social media, and practice management to support sustainable growth in modern fertility care.

Prolactin Levels Are Comparable in Women Regardless of PCOS Status or BMI
Presenting Author: Will Brezina
Authors: Sierra Bishop MD, William Kutteh MD (Fertility Associates of Memphis)

This retrospective cohort study examined prolactin levels in women across varying BMI and PCOS status. The study found that prolactin levels were comparable regardless of PCOS diagnosis or body mass index, suggesting that these factors may not significantly influence baseline prolactin in women undergoing fertility evaluation.

Progestin-Suppressed In Vitro Fertilization Cycles Produce Similar Outcomes to Traditional Protocols in Patients With Diminished Ovarian Reserve
Presenting Author: Linnea Goodman MD (Virginia Fertility & IVF)
Authors: Laura Smith MD, Christopher Williams MD, Scott Purcell PhD (all of Virginia Fertility & IVF), Sara Pierpont MD, Allison Gonzalez MD (both of University of Virginia), Mary Carolyn Peavey MD

This prospective observational cohort study evaluated whether a progestin-suppressed ovarian stimulation protocol in IVF cycles yields outcomes comparable to traditional stimulation approaches in patients with diminished ovarian reserve. The findings indicate that despite lower ovarian reserve, women undergoing the progestin-suppressed protocol achieved similar reproductive outcomes to those using standard protocols, supporting the use of this alternative approach in this challenging patient population.

A Single Center’s Experience With Euploid and Non-Euploid Embryo Transfer: Four Years of Transfer Data of Embryos Identified as Euploid, Mosaic, or Aneuploid via Preimplantation Genetic Testing (PGT)
Presenting Author: Said Daneshmand MD (San Diego Fertility Center)
Authors: Rebecca Gu, Shannon Kokjohn (both of SDFC), Claire Murphy Jones CGC, Amy Jordan CGC, Cengiz Cinnioglu PhD (all of Luminary Genetics)

This retrospective cohort study analyzed four years of transfer data involving embryos classified via preimplantation genetic testing (PGT) as euploid, mosaic, or aneuploid. The findings provide insight into how embryo ploidy status correlates with transfer outcomes and offer real-world context for decision-making in clinical practice.

These research contributions underscore Ivy Fertility’s dedication to advancing reproductive medicine through scientific discovery and clinical excellence.

“With innovations in technology, genetic testing, and clinical protocols, fertility care is evolving at an unprecedented pace,” said Dr. Lowell Ku, ASRM Technology Committee President and physician at Dallas IVF. “It’s exciting to see how collaborative research and creative problem-solving are translating into better outcomes for patients every day.”

By continuously refining fertility treatments and deepening the understanding of human reproduction, Ivy Fertility empowers patients with the most effective, evidence-based care. The insights shared at ASRM 2025 reflect the organization’s ongoing commitment to improving outcomes and making parenthood possible for more individuals and families worldwide.

Other 2025 ASRM presentations by Ivy Fertility team members include:

The Hidden Cost of Trophectoderm Biopsy: Implications for Pregnancy and Live Birth Outcomes Among In Vitro Fertilization (IVF) Cycles Using Donor Oocytes
Presenting Author: Said Daneshmand MD
Authors: Valerie Flores MD, Shannon Kokjohn MSc, Kevin Richter PhD (Fertility Science Consulting)

Ploidy Identification in Preimplantation Genetic Testing for Aneuploidy (PGT-A): “True Euploidy” Rates and Clinical Outcomes of Embryos Developed From Abnormally Fertilized (0PN or 1PN) Oocytes
Presenting Author: Cengiz Cinnioglu PhD
Authors: Said Daneshmand MD, Shannon Kokjohn MSc, Abby Esquivia, Amy Jordan, Claire Murphy Jones CGC, Amy Jordan CGC

The Use of a Luteinizing Hormone Threshold to Determine Timing of Frozen Embryo Transfer Does Not Affect Chance of Success
Presenting Author: Linnea Goodman MD
Authors: Said Daneshmand MD, Shannon Kokjohn MSc, Allison Gonzalez MS, Sara Pierpont MD

Pregnancy and Birth Outcomes According to Blastocyst Expansion Day 5 Through 7 Among Single Cryopreserved Non-Biopsied Blastocyst Transfers
Presenting Author: Valerie Flores MD
Authors: Said Daneshmand MD, Shannon Kokjohn MSc, Kevin Richter PhD

Logistical Pitfalls and Family Planning Delays Associated With Methotrexate Management of Pregnancy of Unknown Location
Presenting Author: Sara Pierpont MD
Authors: Said Daneshmand MD, Linnea Goodman MD, Christopher Williams MD, Laura Smith MD, Shannon Kokjohn MSc

Developing and Growing Your Office-Based Hysteroscopy Program
Chair: Mindy Christianson MD
Faculty: Linnea Goodman MD, John Preston Parry MD, Elliott Richards MD PhD

Progestin-Suppressed In Vitro Fertilization Cycles Produce Similar Outcomes to Traditional Protocols in Patients With Diminished Ovarian Reserve
Presenting Author: Linnea Goodman MD
Authors: Laura Smith MD, Christopher Williams MD, Scott Purcell PhD, Sara Pierpont MD, Allison Gonzalez MS, Mary Peavey MD

Lower Dose HCG Is as Effective as High Dose HCG in Dual Triggered Progestin-Suppressed IVF Cycles
Presenting Author: Lauren Gilgannon MD
Authors: Linnea Goodman MD, Laura Smith MD, Christopher Williams MD, Scott Purcell PhD

Optimizing Oocyte Retrieval Costs
Presenting Author: Sara Pierpont MD
Authors: Linnea Goodman MD, Laura Smith MD, Christopher Williams MD, Hillary Ashley CST

Does Practice Make Perfect? Correlation Between Trial and Actual Embryo Transfer Difficulty
Authors: Linnea Goodman MD, Sara Pierpont MD

Testicular Tissue Workshop: Tips and Tricks to Processing, Cryopreservation and Patient Cycle Management
Chair: Mitchel Schiewe PhD

Principles of Ultra-fast Vitrification and Rapid Rehydration Post-Warming for Oocytes and Embryos
Speaker: Mitchel Schiewe PhD

About Ivy Fertility

Ivy Fertility is globally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and fertility research. The Ivy Fertility network includes Dallas IVF, Fertility Associates of Memphis, Fertility Centers of Orange County, IVF Fertility Center, Los Angeles Reproductive Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center, Northern California Fertility Medical Center, NOVA IVF, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Utah Fertility Center, and Virginia Fertility & IVF. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, Ivy Fertility upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help patients become parents.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251106292942/en/

CONTACT: Constance Rapson

[email protected]

KEYWORD: CALIFORNIA TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SCIENCE WOMEN RESEARCH HEALTH BABY/MATERNITY HEALTH TECHNOLOGY GENETICS CONSUMER

SOURCE: Ivy Fertility

Copyright Business Wire 2025.

PUB: 11/06/2025 02:35 PM/DISC: 11/06/2025 02:36 PM

http://www.businesswire.com/news/home/20251106292942/en